Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma

Por Udhrain, Ashish, Skubitz, Keith M, Northfelt, Donald W
Publicado em 2007

Live, Attenuated Varicella Zoster Vaccination of an Immunocompromised Patient

Por Curtis, Kelly K., Connolly, Megan K., Northfelt, Donald W.
Publicado em 2008

Intersection of Cardiology and Oncology Clinical Practices

Por Mookadam, Farouk, Sharma, Ashwini, Lee, Howard R., Northfelt, Donald W.
Publicado em 2014

Factitious Disorder in Crohn's Disease: Recurrent Pancytopenia Caused by Surreptitious Ingestion of 6-Mercaptopurine

Por Kahn, Allon, Boroff, Erika S., Martin, Kari A., Northfelt, Donald W., Heigh, Russell I.
Publicado no Case Rep Gastroenterol (2015)

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

Por Schuster, Steven R., Pockaj, Barbara A., Bothe, Mary R., David, Paru S., Northfelt, Donald W.
Publicado no J Pers Med (2012)

A Phase II trial of docetaxel and carboplatin administered every two weeks as preoperative therapy for stage II or III breast cancer: NCCTG Study N0338

Por Roy, Vivek, Pockaj, Barbara A., Allred, Jacob B., Apsey, Heidi, Northfelt, Donald W., Nikcevich, Daniel, Mattar, Bassam, Perez, Edith A.
Publicado em 2013

Phase 2 Study of Bevacizumab Plus Erlotinib in Patients With Advanced Hepatocellular Cancer

Por Philip, Philip A., Mahoney, Michelle R., Holen, Kyle D., Northfelt, Donald W., Pitot, Henry C., Picus, Joel, Flynn, Patrick J., Erlichman, Charles
Publicado em 2011

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Por Chiappori, Alberto, Williams, Charles, Northfelt, Donald W., Adams, John W., Malik, Shakun, Edelman, Martin J., Rosen, Peter, Van Echo, David A., Berger, Mark S., Haura, Eric B.
Publicado no J Thorac Oncol (2014)

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

Por Curtis, Kelly K., Sarantopoulos, John, Northfelt, Donald W., Weiss, Glen J., Barnhart, Kerry M., Whisnant, John K., Leuschner, Carola, Alila, Hector, Borad, Mitesh J., Ramanathan, Ramesh K.
Publicado em 2014

Effect of Unblinding on Participants’ Perceptions of Risk and Confidence in a Large Double-blind Clinical Trial of Chemotherapy for Breast Cancer

Por Partridge, Ann H., Sepucha, Karen, O’Neill, Anne, Miller, Kathy D., Motley, Christine, Swaby, Ramona F., Schneider, Bryan P., Dang, Chau T., Northfelt, Donald W., Sledge, George W.
Publicado no JAMA Oncol (2015)

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

Por Kearns, Ann E., Northfelt, Donald W., Dueck, Amylou C., Atherton, Pamela J., Dakhil, Shaker R., Rowland, Kendrith M., Fuloria, Jyotsna, Flynn, Patrick J., Dentchev, Todor, Loprinzi, Charles L.
Publicado em 2009

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103

Por Ruddy, Kathryn J., O'Neill, Anne, Miller, Kathy D., Schneider, Bryan P., Baker, Emily, Sparano, Joseph A., Dang, Chau, Northfelt, Donald W., Sledge, George W., Partridge, Ann H.
Publicado no Breast Cancer Res Treat (2014)

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

Por Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Publicado em 2012

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial()

Por Galanis, Evanthia, Anderson, S. Keith, Lafky, Jackie M., Uhm, Joon H., Giannini, Caterina, Kumar, Shaji K., Kimlinger, Teresa K., Northfelt, Donald W., Flynn, Patrick J., Jaeckle, Kurt A., Kaufmann, Timothy J., Buckner, Jan C.
Publicado em 2013

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Por Barrett, Michael T., Anderson, Karen S., Lenkiewicz, Elizabeth, Andreozzi, Mariacarla, Cunliffe, Heather E., Klassen, Christine L., Dueck, Amylou C., McCullough, Ann E., Reddy, Srikanth K., Ramanathan, Ramesh K., Northfelt, Donald W., Pockaj, Barbara A.
Publicado no Oncotarget (2015)

Metastasectomy and Surgical Resection of the Primary Tumor in Patients With Stage IV Breast Cancer: Time for a Second Look?

Por Pockaj, Barbara A., Wasif, Nabil, Dueck, Amylou C., Wigle, Dennis A., Boughey, Judy C., Degnim, Amy C., Gray, Richard J., McLaughlin, Sarah A., Northfelt, Donald W., Sticca, Robert P., Jakub, James W., Perez, Edith A.
Publicado em 2010

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

Por Ingle, James N., Kalari, KR, Buzdar, Aman U., Robson, Mark E., Goetz, Matthew P., Desta, Zeruesenay, Barman, Poulami, Dudenkov, Tanda T., Northfelt, Donald W., Perez, Edith A., Flockhart, David A., Williard, Clark V., Wang, Liewei, Weinshilboum, Richard M.
Publicado no Steroids (2014)

Evaluation of CYP2D6 enzyme activity using a Dextromethorphan Breath Test in Women Receiving Adjuvant Tamoxifen

Por Safgren, Stephanie L., Suman, Vera J., Kosel, Matthew L., Gilbert, Judith A, Buhrow, Sarah A., Black, John L., Northfelt, Donald W., Modak, Anil S., Rosen, David, Ingle, James N., Ames, Matthew M., Reid, Joel M., Goetz, Matthew P.
Publicado no Pharmacogenet Genomics (2015)

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

Por Ingle, James N., Buzdar, Aman U., Schaid, Daniel J., Goetz, Matthew P., Batzler, Anthony, Robson, Mark E., Northfelt, Donald W., Olson, Janet E., Perez, Edith A., Desta, Zeruesenay, Weintraub, Randy A., Williard, Clark V., Flockhart, David A., Weinshilboum, Richard M.
Publicado em 2010

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321

Por Zhao, Yujie, Foster, Nathan R., Meyers, Jeffrey P., Thomas, Sachdev P., Northfelt, Donald W., Rowland, Kendrith M., Mattar, Bassam I., Johnson, David B., Molina, Julian R., Mandrekar, Sumithra J., Schild, Steven E., Bearden, James D., Aubry, Marie-Christine, Adjei, Alex A.
Publicado no J Thorac Oncol (2015)